文献速递乳房整形与再造创面修复

大容量浓缩活性脂肪移植用于乳房全再造

Total breast reconstruction using large-volume condensed and viable fat grafting after mastectomy.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-11-26

本研究对30例乳房切除术后患者采用大容量浓缩活性脂肪移植行乳房全再造,其中放疗9例、未放疗21例。每例平均移植脂肪230.5 mL,平均3.3次,放疗患者需更多次数(p=.017)。美学评分显著改善(p<.001),约90%患者满意,无局部复发或远处转移。

要点

  • 大容量浓缩活性脂肪移植可作为乳房切除术后乳房再造的第三选择。
  • 放疗患者需要更多移植次数(p=.017),应预期更高疗程负担。
  • 并发症包括囊肿(27%)、可触及结节(3%)和感染(3%),需术后监测。

核心结论

  • 大容量浓缩活性脂肪移植行乳房全再造对乳房切除术后患者有效且安全。

研究设计与样本

  • 对30例乳房切除术后患者行大容量浓缩活性脂肪移植乳房全再造,放疗9例、未放疗21例。
  • 脂肪经洗涤和棉纱布滚动技术纯化浓缩,平均随访12.8个月。

主要发现

  • 每次手术平均移植脂肪230.5 mL,平均手术次数3.3次。
  • 放疗患者所需手术次数多于未放疗患者(p=.017)。
  • 美学评分治疗后显著改善(p<.001),约90%患者满意。
  • 术后感染1例(3%),囊肿8例(27%),可触及结节1例(3%)。
  • 随访期间无局部复发或远处转移记录。

关键数值与推荐

  • 每次手术平均移植脂肪体积230.5(57.8)mL。
  • 平均手术次数3.3(0.7)次;放疗患者需更多次数(p=.017)。
  • 平均随访12.8(4.3)个月。
  • 囊肿发生率27%,可触及结节发生率3%,感染发生率3%。

临床怎么用

  • 可将大容量浓缩活性脂肪移植作为乳房切除术后乳房再造的第三选择。
  • 对放疗患者应预期更多移植次数并做好术前沟通。
  • 术后需关注囊肿、可触及结节和感染等并发症。

局限性

  • 样本量30例,随访时间平均12.8个月,长期肿瘤学安全性需更久随访。
  • 部分患者使用Brava装置扩张受区,可能影响结果泛化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autologous fat grafting (AFG) has become a third alternative for breast reconstruction after mastectomy. However, total breast reconstruction using AFG remains a great challenge. We performed breast reconstruction using large-volume condensed and viable fat grafting in 30 postmastectomy patients (irradiated, n = 9; nonirradiated, n = 21). The grafts were purified and condensed by the washing and cotton gauze rolling technique. The surgical maneuver is designed to preserve the grafts viability. Three-dimensional expansion was applied where strong adhesions were present. Seven patients wore the Brava device for the expansion of the recipient site. The mean (SD) volume of fat grafted in each procedure was 230.5 (57.8) mL. The average number of sessions was 3.3 (0.7). The irradiated patients required more sessions than the nonirradiated patients (p=.017). The mean follow-up period was 12.8 (4.3) months. One patient (3%) developed postoperative cellulitis. Cysts and palpable nodules occurred in eight patients (27%) and one patient (3%), respectively. Severe dermatitis and skin pigmentation change occurred in one patient wearing the Brava device. The esthetic scores significantly improved after the treatments (p<.001). Approximately 90% of the patients were satisfied. No local recurrence or remote metastasis was documented during the follow-up period. Our study showed the success of total breast reconstruction using AFG. As a third alternative for breast reconstruction, total breast reconstruction using large volume condensed and viable fat grafting is an effective and safe approach for postmastectomy patients.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Zhang X, Cai L, Yin B, et al. Total breast reconstruction using large-volume condensed and viable fat grafting after mastectomy. J Plast Reconstr Aesthet Surg. 2020. PMID: 33341385. doi:10.1016/j.bjps.2020.10.109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。